Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Prediction of eGFR and uACR Using Evolutionary Learning for Identifying High-Risk Individuals in Renal Disease Prevention.

Created on 20 Nov 2026

Authors

Yao-Feng Hu, Chia-Heng Yen, Yen-Cheng Lin, Ting-Yu Chen, Shinn-Ying Ho

Published in

Journal of clinical laboratory analysis. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

Many individuals at high risk for renal disease remain undetected in clinical practice due to insufficient testing of estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (uACR). This study aims to develop models to predict reduced eGFR and elevated uACR, thereby facilitating early identification of individuals at risk.
From 72,346 analyzed samples, we derived a dataset containing 15 features (U15). We developed three evolutionary learning-based models: PeGFR, PuACR1, and PuACR2, to predict eGFR < 60 mL/min/1.73 m2, uACR ≥ 30 mg/g, and uACR > 300 mg/g, respectively. These models were built using an intelligent bi-objective combinatorial genetic algorithm (IBCGA) and SVM parameter settings optimized simultaneously. External dataset without eGFR and uACR measurements to evaluate clinical applicability.
In the U15 training and test datasets for uACR prediction, gender, pH, and bilirubin were not statistically significant; whereas all features were significant in eGFR prediction (p < 0.05). The areas under the curve (AUC) for PeGFR, PuACR1, and PuACR2 were 0.846, 0.827, and 0.949, respectively. In the external test, 589 individuals (11.36%) were identified as high- or very-high-risk, defined as having eGFR < 60 mL/min/1.73 m2 and uACR ≥ 30 mg/g.
The evolutionary learning framework proposed accurately predicts renal risk using clinical data as an early screening tool. It also demonstrates scalability in assisting healthcare providers in determining whether further renal-related examinations are warranted, thereby facilitating the identification of high-risk individuals for secondary prevention. An online tool has also been developed for clinical and research use: https://nycuiclab.ngrok.io.

PMID:
43056505
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement